
Italian Duchenne Muscular Dystrophy Drug Okayed in Europe
Europe’s Committee for Medicinal Products for Human Use (CHMP) has recommended granting a conditional marketing authorization for Duvyzat (givinostat, Italfarmaco) to treat Duchenne muscular dystrophy (DMD) in patients aged 6 years and older who can walk. …